1. Home
  2. PJT vs AMRX Comparison

PJT vs AMRX Comparison

Compare PJT & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PJT Partners Inc.

PJT

PJT Partners Inc.

HOLD

Current Price

$155.10

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$16.22

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PJT
AMRX
Founded
2014
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.0B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
PJT
AMRX
Price
$155.10
$16.22
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$178.50
$15.60
AVG Volume (30 Days)
297.1K
1.8M
Earning Date
04-28-2026
05-01-2026
Dividend Yield
0.66%
N/A
EPS Growth
N/A
157.89
EPS
N/A
0.19
Revenue
$1,713,671,000.00
N/A
Revenue This Year
$11.12
$4.48
Revenue Next Year
$9.98
$7.13
P/E Ratio
$23.03
$85.53
Revenue Growth
14.77
N/A
52 Week Low
$127.73
$7.67
52 Week High
$195.62
$16.61

Technical Indicators

Market Signals
Indicator
PJT
AMRX
Relative Strength Index (RSI) 49.71 79.75
Support Level $148.69 $12.46
Resistance Level $163.37 N/A
Average True Range (ATR) 5.45 0.53
MACD -0.23 0.32
Stochastic Oscillator 37.27 91.02

Price Performance

Historical Comparison
PJT
AMRX

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services, and others. Geographically, it generates maximum revenue from the United States, followed by the United Kingdom and other markets.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: